<DOC>
	<DOCNO>NCT00852124</DOCNO>
	<brief_summary>We propose test safety probiotic , VSL # 3 , placebo control double blind safety study 30 asthmatic adult . This adult safety trial request FDA IND review pediatric asthma protocol . Adults doctor diagnosis persistent asthma take VSL # 3 placebo twice daily 3 month . Data collect , include age , race , height , weight , present medication , past medical history emphasis signs/symptoms asthma . On visit clinic evaluate - Changes lung function - Intestinal permeability - Intestinal bacteria - Levels inflammation blood - Women repeat urine pregnancy test clinic visit</brief_summary>
	<brief_title>Safety VSL # 3 Adult Asthmatics</brief_title>
	<detailed_description>The monitored parameter assess clinic visit phone call include : 1. number day asthma relate symptom cough , wheeze , dyspnea , awaken night , exercise limitation . 2. number asthma-related missed school/work day 3. amount use asthma rescue medication 4. use non-inhaled steroid 5. change medication baseline visit 6. diarrhea/liquid stool ( &gt; 2/day ) 7. constipation 8. gas/bloating 9. fever/chills 10. schedule unscheduled visit health care To monitor increased risk safety concern , also inquire follow visit phone call follow : 1. household member immunosuppression HIV chemotherapy . On visit clinic evaluate lung function spirometry : 1. change lung function spirometry . 2. woman childbearing potential repeat urine pregnancy test clinic visit . 3. intestinal barrier function 4. intestinal flora 5. serum inflammatory cytokine IgE</detailed_description>
	<criteria>1 . Adults age 1864 year old . 2 . Doctor diagnosis mild persistent asthma . Persistent asthma define NAEPP guideline asthma symptom ( cough/wheeze/dyspnea/exercise limitation ) great 2 times/week daytime great 2 times/month night previous month less continual less 5 nights/week . 3 . FEV1 great 60 % predict age/gender/race/height base normative data . 4 . No unscheduled asthma related health visit 1 month prior enrollment 5 . School work day miss less equal 2 previous month asthma . 6 . Albuterol use less 8 dos ( 2 puff one neb ) past week . 7 . Ability speak understand English . 8 . Telephone access . 9 . Women childbearing potential must confirm use birth control study negative urine pregnancy screen baseline . 1 . Pregnant woman , prisoner . 2 . Chronic illness ( asthma , allergic rhinitis eczema ) renal disease , diabetes , hypertension terminal disease abnormal vital sign : T &gt; 100.3F , HR &gt; 130 bpm , SBP &gt; 155 mmHg , DBP &gt; 100 mmHg , RR &gt; 25 bpm , pox &lt; 93 % room air . 3 . Unable perform spirometry , necessary lung function assessment . 4 . Received probiotic past 6 month . 5 . Subject household member immunosuppression HIV , history organ transplantation , present cancer chemotherapy , primary immune disease , take immune modulate drug . 6 . Severe persistent asthmatic continual daily frequent ( great 5 nights/week ) asthma symptom and/or FEV1 le 60 % predict . 7 . Diarrhea constipation ( symptom past week ) 8 . Unable feed orally consume cornstarch 9 . Lung disease asthma ( e.g . COPD , cystic fibrosis , lung cancer , bronchiectasis , interstitial lung disease ) . 10 . Subjects increase risk develop infective endocarditis history cardiac surgery , IV drug abuse , recent invasive medical procedure dental work ( recent = last month ) . 11 . Allergy Vancomycin Cefepime . The parameter intestinal barrier function , intestinal flora , serum inflammatory cytokine , IgE , exclusion range collect time product way describe population characteristic study participant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Probiotic</keyword>
	<keyword>VSL # 3</keyword>
</DOC>